Skip to Primary Navigation

Medicare paid nearly $380m for organs not used in covered transplants

Seal of the US Department of Health and Human Services on Glass Door at HHS headquarters.
Photo: Kevin Carter/Getty Images

Medicare paid transplant centers for organs never used, an audit finds, prompting calls to tighten oversight and clarify conflicting federal rules.

Medicare paid an estimated $380m over six years for organs that were not ultimately used in Medicare-covered transplants, according to a new report from the Department of Health and Human Services Office of Inspector General (HHS-OIG).

The report found that the Medicare program reimbursed certified transplant centers an estimated $379.9m

Get full access, free for a month

Start your 28-day free trial to continue reading and accessall content on GRIP – no payment details required.

What’s included:

  • Every new article, plus our 5,000+ archive
  • Daily regulatory insight and guidance
  • Exclusive interviews and in-depth analysis
  • Coverage of industry-leading events and conferences
  • All podcasts and videos, featuring industry experts
  • The full set of Rules Navigator tools
  • An ad-free experience